CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology

CENTOGENE is excited to announce their latest scientific publication in The Lancet Neurology – demonstrating a significant link between the RAB32 gene variant and Parkinson's disease.

To read more about how this data from the largest international genetic Parkinson’s patient cohort shows that the RAB32 mutation is over 100 times more prevalent in Parkinson's patients than in the general population, click here.

For more information on Centogene, please contact our SciencewerkeDX representative, Saba
at [email protected] or call: +65 98254866.